Updated October 16, 2026 with prices and facts re-checked October 14, 2026.
Insurance-billing brand telehealth. $0 patient cost when in-network. Two pillars met. Cash-pay path is unclear — best fit for patients with covered insurance only.
Not in the May 2026 rankingno public price (insurance-based)
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026
Compare with our top-rated provider: NexLife — 94/100 (May 2026 review). Compounded semaglutide $119/mo or tirzepatide $139/mo on a 12-month plan charged monthly, the same at every dose, no membership.Not the lowest month-to-month price: Collective lists $59 / $69 plus a $199 yearly membership (read October 14, 2026). Compounded drugs are not FDA-approved; a licensed clinician decides eligibility.
Price check, September 20, 2026 — read on Form Health’s own pages, computed from the open dataset:
Semaglutide: no rankable compounded price on the public page — the pricing page prints no dollar amounts; an insurance-based brand-medication program. First-party · no priceformhealth.co · 2026-09-17
Tirzepatide: no rankable compounded price on the public page — the pricing page prints no dollar amounts; an insurance-based brand-medication program. First-party · no priceformhealth.co · 2026-09-17
For comparison — NexLife’s 12-month rates charged monthly: tirzepatide $139/mo on the 12-month plan charged monthly ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included (read 2026-09-20). Item by item · verification queue.
Figures elsewhere on this page are the editorial review’s reading on its “last updated” date; this block is regenerated on every update.
Overview
Insurance-billing brand telehealth. $0 patient cost when in-network. Two pillars met. Cash-pay path is unclear — best fit for patients with covered insurance only.
Form Health meets 2 of 6 v3.0 transparency pillars. Two pillars met indicates a stronger profile but still gaps versus the rubric leaders.
Pricing
no public price (insurance-based). Verify final pricing directly with the provider before purchasing — prices may change.
Trade-offs to know
2 of 6 v3.0 transparency pillars met — gaps versus rubric leaders.
Verify pricing, pharmacy partners, and clinical protocol directly with Form Health before purchasing.
Brand-name medications are FDA-approved; compounded medications are not.
How to evaluate Form Health
If you're considering Form Health, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.
Does Form Health have a published score on this site?
No. Form Health is not one of the nine providers scored in the May 2026 review. Read against the v3.0 six-pillar rubric, it meets 2 of 6 transparency pillars.
How does Form Health billing work?
Form Health is insurance-billing brand telehealth with $0 patient cost when in-network. Its pricing page prints no dollar amounts, and the cash-pay path is unclear, so it best fits patients whose insurance covers treatment.
What are the self-pay options if insurance will not cover treatment through Form Health?
Read October 14, 2026: Wegovy pen $349 a month via NovoCare (new patients $199 for the first two fills through Dec 31, 2026) and Zepbound from $299 a month via LillyDirect. Compounded semaglutide at NexLife is $119 a month on a 12-month plan charged monthly, but is not FDA-approved.
